Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 80.20
-4.10 (-4.86%)
At close: Mar 3, 2026
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.34 billion as of March 3, 2026. Its market cap has increased by 379.17% in one year.
Market Cap
5.34B
Enterprise Value
5.26B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
80.20
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.34B, an increase of 138.56%. That is a compound annual growth rate of 55.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.34B | 33.44% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 5.93B |
| Sinphar Pharmaceutical | 5.83B |
| CHO Pharma | 5.62B |
| AnnJi Pharmaceutical | 5.60B |
| Locus Cell | 5.40B |
| UnicoCell Biomed | 5.32B |
| Panion & Bf Biotech | 5.29B |
| OBI Pharma | 5.25B |